Innovation Pharmaceuticals Inc (IPIX)

[Amatuer17]

What promising results - it is just shown safety - it is so diluted and short life that it was not reaching high concentration due to weekly dosing

When they 3 doses per week - we can possibly see what is maximum concentration that reaches and whether it is therapeutic level.

So until Leo addresses the short half life issue -(by possibly oral formulation) - K is a dud - if Leo sees not so good results of current K trial - he will delay the progress but will not say K is not as good as he thought.